Kinesia HomeView - Home Diary Comparison

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01920425

Enrollment

Registered

2013-08-12

Start date

2013-07-31

Completion date

2015-09-30

Last updated

2016-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's Disease

Keywords

Parkinson's disease, dyskinesia, fluctuations, tremor, bradykinesia, levodopa

Brief summary

The objective is to compare the sensitivity and test-retest reliability of Kinesia HomeView to electronic and hand-written diaries for tracking medication state in the home. Demonstrating comparable or superior results will further support use of the Kinesia HomeView system as an outcome measure in clinical drug trials.

Interventions

DEVICEKinesia HomeView

Motion sensor based telemedicine system for assessment of movement disorder motor symptoms in the home. Includes automated motor assessment using motion sensor and electronic dyskinesia diary.

OTHERHand-written diary

Hand-written paper diary indicating state (Off, On without dyskinesias, on with non-troublesome dyskinesias, on with troublesome dyskinesias) at 30 minute intervals.

Study design

Allocation

RANDOMIZED

Intervention model

CROSSOVER

Primary purpose

DIAGNOSTIC

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Clinical diagnosis of Parkinson's disease * On a stable antiparkinsonian medication regimen that includes levodopa for at least 4 weeks * Experiencing dyskinesia more than 25% of the waking day (score ≥ 2 on Unified Parkinson's Disease Rating Scale item 32) * With dyskinesias at least moderately disabling (score ≥ 2 on Unified Parkinson's Disease Rating Scale item 33) * Capable of accurately completing diaries * Capable of accurately using Kinesia HomeView

Exclusion criteria

* Significant medical or psychiatric illness * Subjects not capable of following the required clinical instructions * Serious medical conditions that would compromise safety

Design outcomes

Primary

Measure	Time frame	Description
Test-retest reliability	4 weeks	Test-retest reliability will be compared between Kinesia HomeView measures, hand-written diary entries, and electronic diary entries.

Secondary

Measure	Time frame	Description
Kinesia HomeView usability questionnaire	After 4 weeks	Questionnaires on the usability of Kinesia HomeView will be completed following the 4-week data collection period.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026